Leukemia & Lymphoma, Volume 56, Issue 6 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 56, Issue 6 (2015)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Volume 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentary on selected article in this issue

Article Commentary
Calreticulin gene mutations in the myeloproliferative neoplasms: Dameshek's other “myelostimulatory” factor
Brady L. Stein & Leonidas C. Platanias
Pages: 1573-1574
Published online: 14 Jan 2015
CitationforCalreticulin gene mutations in the myeloproliferative neoplasms: Dameshek's other “myelostimulatory” factor | Full Text | References | PDF (94.2 KB) | Supplemental
  • 187 Views
  • 1 CrossRef citations
  • 0Altmetric
Article Commentary
Second cancers in chronic lymphocytic leukemia: growing importance in the era of improved treatment outcomes
Petra Langerbeins, Christian Maurer, Paula Cramer, Barbara Eichhorst & Michael Hallek
Pages: 1575-1576
Published online: 12 May 2015
CitationforSecond cancers in chronic lymphocytic leukemia: growing importance in the era of improved treatment outcomes | Full Text | References | PDF (85.2 KB) | Supplemental
  • 236 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Pneumonitis following immunochemotherapy with rituximab: a new well-designed retrospective study to better assess the risks
Hervé Ghesquières
Pages: 1577-1578
Published online: 19 Nov 2014
CitationforPneumonitis following immunochemotherapy with rituximab: a new well-designed retrospective study to better assess the risks | Full Text | References | PDF (86 KB) | Supplemental
  • 162 Views
  • 2 CrossRef citations
  • 0Altmetric
Article Commentary
Bortezomib followed by autologous stem cell transplant for patients with hepatitis B positive multiple myeloma: a cautionary note
Deborah Rund
Pages: 1579-1580
Published online: 19 Feb 2015
CitationforBortezomib followed by autologous stem cell transplant for patients with hepatitis B positive multiple myeloma: a cautionary note | Full Text | References | PDF (85.4 KB) | Supplemental
  • 174 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Overcoming treatment challenges in imatinib-resistant chronic myelogenous leukemia
Dany A. Curi, Elspeth M. Beauchamp & Leonidas C. Platanias
Pages: 1581-1582
Published online: 05 Nov 2014
CitationforOvercoming treatment challenges in imatinib-resistant chronic myelogenous leukemia | Full Text | References | PDF (89.9 KB) | Supplemental
  • 115 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Secondary diffuse large B-cell lymphoma of the central nervous system: the need for better predictors
Mark Roschewski & Kieron Dunleavy
Pages: 1583-1584
Published online: 23 Jun 2015
CitationforSecondary diffuse large B-cell lymphoma of the central nervous system: the need for better predictors | Full Text | References | PDF (90.3 KB) | Supplemental
  • 193 Views
  • 2 CrossRef citations
  • 0Altmetric

Review

Review Article
Past, present and future role of chlorambucil in the treatment of chronic lymphocytic leukemia
Valentin Goede, Barbara Eichhorst, Kirsten Fischer, Clemens-Martin Wendtner & Michael Hallek
Pages: 1585-1592
Published online: 20 Nov 2014
AbstractforPast, present and future role of chlorambucil in the treatment of chronic lymphocytic leukemia | Full Text | References | PDF (151.8 KB) | Supplemental
  • 968 Views
  • 15 CrossRef citations
  • 0Altmetric
Review Article
Calreticulin gene mutations in myeloproliferative neoplasms without Janus kinase 2 mutations
Chao Sun, Sujiang Zhang & Jianyong Li
Pages: 1593-1598
Published online: 07 Oct 2014
AbstractforCalreticulin gene mutations in myeloproliferative neoplasms without Janus kinase 2 mutations | Full Text | References | PDF (518.3 KB) | Supplemental
  • 417 Views
  • 7 CrossRef citations
  • 0Altmetric
Review Article
How applicable is fludarabine, cyclophosphamide and rituximab to the elderly?
Nimish Shah, Constantine Tam, John F. Seymour & Simon Rule
Pages: 1599-1610
Published online: 20 Nov 2014
AbstractforHow applicable is fludarabine, cyclophosphamide and rituximab to the elderly? | Full Text | References | PDF (166.5 KB) | Supplemental
  • 465 Views
  • 8 CrossRef citations
  • 0Altmetric
Review Article
Risk and prophylaxis strategy of hepatitis B virus reactivation in patients with lymphoma undergoing chemotherapy with or without rituximab
Sung-Nan Pei & Chien-Hung Chen
Pages: 1611-1618
Published online: 20 Feb 2015
AbstractforRisk and prophylaxis strategy of hepatitis B virus reactivation in patients with lymphoma undergoing chemotherapy with or without rituximab | Full Text | References | PDF (440.7 KB) | Supplemental
  • 514 Views
  • 7 CrossRef citations
  • 0Altmetric
Review Article
The prognostic impact of peripheral blood progenitor cell dose following high-dose therapy and autologous stem cell transplant for hematologic malignancies
Craig S. Sauter & Sergio Giralt
Pages: 1619-1625
Published online: 03 Nov 2014
AbstractforThe prognostic impact of peripheral blood progenitor cell dose following high-dose therapy and autologous stem cell transplant for hematologic malignancies | Full Text | References | PDF (415.1 KB) | Supplemental
  • 332 Views
  • 5 CrossRef citations
  • 0Altmetric
Review Article
Paradigm shifts in the management of poor-risk chronic lymphocytic leukemia
Racquel D. Innis-Shelton, Randall S. Davis, Lawrence Lamb & Shin Mineishi
Pages: 1626-1635
Published online: 08 Jan 2015
AbstractforParadigm shifts in the management of poor-risk chronic lymphocytic leukemia | Full Text | References | PDF (165.1 KB) | Supplemental
  • 241 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article: Clinical

Article
High CD20+ background cells predict a favorable outcome in classical Hodgkin lymphoma and antagonize CD68+ macrophages
Luigi Panico, Valentina Tenneriello, Fioravante Ronconi, Marianna Lepore, Nicola Cantore, Antonietta Carmela Dell’Angelo, Ludovica Ferbo & Felicetto Ferrara
Pages: 1636-1642
Published online: 03 Nov 2014
AbstractforHigh CD20+ background cells predict a favorable outcome in classical Hodgkin lymphoma and antagonize CD68+ macrophages | Full Text | References | PDF (337.8 KB) | Supplemental
  • 226 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes
Ohad Benjamini, Preetesh Jain, Long Trinh, Wei Qiao, Sara S. Strom, Susan Lerner, Xuemei Wang, Jan Burger, Alessandra Ferrajoli, Hagop Kantarjian, Susan O'Brien, William Wierda, Zeev Estrov & Michael Keating
Pages: 1643-1650
Published online: 19 Nov 2014
AbstractforSecond cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes | Full Text | References | PDF (621.6 KB) | Supplemental
  • 1027 Views
  • 111 CrossRef citations
  • 0Altmetric
Article
A simplified scoring system to document variant patterns in nodular lymphocyte predominant Hodgkin lymphoma
Tanuja Shet, Poonam Panjwani, Sridhar Epari, Manju Sengar, Maya Prasad, Brijesh Arora, Siddhartha Laskar, Sumeet Gujral, Hari Menon & Shripad Banavali
Pages: 1651-1658
Published online: 20 Nov 2014
AbstractforA simplified scoring system to document variant patterns in nodular lymphocyte predominant Hodgkin lymphoma | Full Text | References | PDF (3.5 MB) | Supplemental
  • 277 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
Incidence of pneumonitis in patients with non-Hodgkin lymphoma receiving chemoimmunotherapy with rituximab
Giselle Salmasi, Michael Li, Vithika Sivabalasundaram, Tony Panzarella, Richard Tsang, Vishal Kukreti, Michael Crump & John Kuruvilla
Pages: 1659-1664
Published online: 30 Oct 2014
AbstractforIncidence of pneumonitis in patients with non-Hodgkin lymphoma receiving chemoimmunotherapy with rituximab | Full Text | References | PDF (271.7 KB) | Supplemental
  • 590 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Survival in patients with limited-stage peripheral T-cell lymphomas
Robert Briski, Andrew L. Feldman, Nathaniel G. Bailey, Megan S. Lim, Kay Ristow, Thomas M. Habermann, William R. Macon, David J. Inwards, Joseph P. Colgan, Grzegorz S. Nowakowski, Mark S. Kaminski, Thomas E. Witzig, Stephen M. Ansell & Ryan A. Wilcox
Pages: 1665-1670
Published online: 30 Oct 2014
AbstractforSurvival in patients with limited-stage peripheral T-cell lymphomas | Full Text | References | PDF (199.2 KB) | Supplemental
  • 520 Views
  • 14 CrossRef citations
  • 0Altmetric
Article
Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practice
Pier Luigi Zinzani, Luigi Rigacci, Maria Cristina Cox, Liliana Devizzi, Alberto Fabbri, Alfonso Zaccaria, Francesco Zaja, Alice Di Rocco, Giuseppe Rossi, Sergio Storti, Pier Paolo Fattori, Lisa Argnani, Sante Tura & Umberto Vitolo
Pages: 1671-1676
Published online: 19 Nov 2014
AbstractforLenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practice | Full Text | References | PDF (243.9 KB) | Supplemental
  • 967 Views
  • 18 CrossRef citations
  • 0Altmetric
Article
Occurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders
Maja Ølholm Vase, Eva Futtrup Maksten, Knud Bendix, Stephen Hamilton-Dutoit, Claus Andersen, Michael Boe Møller, Søren Schwartz Sørensen, Bente Jespersen, Jan Kampmann, Esben Søndergård, Patricia Switten Nielsen & Francesco D’amore
Pages: 1677-1685
Published online: 21 Jan 2015
AbstractforOccurrence and prognostic relevance of CD30 expression in post-transplant lymphoproliferative disorders | Full Text | References | PDF (433.4 KB) | Supplemental
  • 699 Views
  • 30 CrossRef citations
  • 0Altmetric
Article
Does the presence of hepatitis virus B and C influence the evolution of diffuse large B-cell lymphoma?
Judit Rubio, Fernando Franco, Antonio Sánchez, Blanca Cantos, Miriam Méndez, Virginia Calvo, Constanza Maximiano, David Perez, Isabel Millán, Margarita Sánchez-Beato & Mariano Provencio
Pages: 1686-1690
Published online: 20 Nov 2014
AbstractforDoes the presence of hepatitis virus B and C influence the evolution of diffuse large B-cell lymphoma? | Full Text | References | PDF (275 KB) | Supplemental
  • 283 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus idarubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia
Jie Jin, Jian Chen, Shanshan Suo, Wenbin Qian, Haitao Meng, Wenyuan Mai, Hongyan Tong, Jian Huang, Wenjuan Yu, Juyin Wei & Yinjun Lou
Pages: 1691-1697
Published online: 03 Nov 2014
AbstractforLow-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor priming regimen versus idarubicin plus cytarabine regimen as induction therapy for older patients with acute myeloid leukemia | Full Text | References | PDF (194.4 KB) | Supplemental
  • 477 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Presentation and outcomes among patients with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysis
Maryam Movassaghian, Andrew M. Brunner, Traci M. Blonquist, Hossein Sadrzadeh, Ashmeet Bhatia, Ashley M. Perry, Eyal C. Attar, Philip C. Amrein, Karen K. Ballen, Donna S. Neuberg & Amir T. Fathi
Pages: 1698-1703
Published online: 09 Oct 2014
AbstractforPresentation and outcomes among patients with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysis | Full Text | References | PDF (792 KB) | Supplemental
  • 907 Views
  • 58 CrossRef citations
  • 0Altmetric
Article
Single nucleotide polymorphisms in non-coding region of the glucocorticoid receptor gene and prednisone response in childhood acute lymphoblastic leukemia
Lu Xue, Chunhuai Li, Yue Wang, Wei Sun, Cui Ma, Yongyan He, Yongli Yu, Lu Cai & Liying Wang
Pages: 1704-1709
Published online: 11 Feb 2015
AbstractforSingle nucleotide polymorphisms in non-coding region of the glucocorticoid receptor gene and prednisone response in childhood acute lymphoblastic leukemia | Full Text | References | PDF (410.1 KB) | Supplemental
  • 172 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Hepatitis B virus reactivation in patients with multiple myeloma receiving bortezomib-containing regimens followed by autologous stem cell transplant
Juan Li, Beihui Huang, Ying Li, Dong Zheng, Zhenhai Zhou & Junru Liu
Pages: 1710-1717
Published online: 14 Jan 2015
AbstractforHepatitis B virus reactivation in patients with multiple myeloma receiving bortezomib-containing regimens followed by autologous stem cell transplant | Full Text | References | PDF (951.9 KB) | Supplemental
  • 655 Views
  • 30 CrossRef citations
  • 0Altmetric
Article
Lack of objective response of myelodysplastic syndromes and acute myeloid leukemia to decitabine after failure of azacitidine
Vu H. Duong, Bhavana Bhatnagar, Dan P. Zandberg, Emily J. Vannorsdall, Michael L. Tidwell, Qing Chen & Maria R. Baer
Pages: 1718-1722
Published online: 03 Nov 2014
AbstractforLack of objective response of myelodysplastic syndromes and acute myeloid leukemia to decitabine after failure of azacitidine | Full Text | References | PDF (121 KB) | Supplemental
  • 702 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
Therapy-related myelodysplastic syndrome/acute leukemia after multiple myeloma in the era of novel agents
Morie A. Gertz, Evangelos Terpos, Angela Dispenzieri, Shaji Kumar, Rupin A. Shah, Robert Orlowski, Efstathios Kastritis, Meletios A. Dimopoulos & Jatin Shah
Pages: 1723-1726
Published online: 03 Nov 2014
AbstractforTherapy-related myelodysplastic syndrome/acute leukemia after multiple myeloma in the era of novel agents | Full Text | References | PDF (165.5 KB) | Supplemental
  • 749 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
Spontaneous remission of acute myeloid leukemia
Armin Rashidi & Stephen I. Fisher
Pages: 1727-1734
Published online: 03 Nov 2014
AbstractforSpontaneous remission of acute myeloid leukemia | Full Text | References | PDF (406.7 KB) | Supplemental
  • 960 Views
  • 24 CrossRef citations
  • 0Altmetric
Article
High-sensitivity flow cytometric analysis of mast cell clustering in systemic mastocytosis: a quantitative and statistical analysis
Olga Pozdnyakova, Charlotte D. Laplante, Betty Li, Bernard Rosner & David M. Dorfman
Pages: 1735-1741
Published online: 03 Nov 2014
AbstractforHigh-sensitivity flow cytometric analysis of mast cell clustering in systemic mastocytosis: a quantitative and statistical analysis | Full Text | References | PDF (668.8 KB) | Supplemental
  • 201 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Combining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma
Idun Fiskvik, Klaus Beiske, Jan Delabie, Olav Yri, Signe Spetalen, Marja-Liisa Karjalainen-Lindsberg, Sirpa Leppä, Knut Liestøl, Erlend B Smeland & Harald Holte
Pages: 1742-1749
Published online: 19 Nov 2014
AbstractforCombining MYC, BCL2 and TP53 gene and protein expression alterations improves risk stratification in diffuse large B-cell lymphoma | Full Text | References | PDF (1 MB) | Supplemental
  • 559 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Phase II study of 90Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma
Izidore S. Lossos, Jesus C. Fabregas, Tulay Koru-Sengul, Feng Miao, Deborah Goodman, Aldo N. Serafini, Peter J. Hosein, Alexandra Stefanovic, Joseph D. Rosenblatt & James E. Hoffman
Pages: 1750-1755
Published online: 20 Nov 2014
AbstractforPhase II study of 90Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma | Full Text | References | PDF (188.6 KB) | Supplemental
  • 514 Views
  • 22 CrossRef citations
  • 0Altmetric
Article
Comparative effectiveness analysis of different salvage therapy intensities used for diffuse large B-cell lymphoma in Northern or Southern Alberta: an instrumental variable analysis
Danielle H. Oh, Sunita Ghosh, Neil Chua, Xanthoula Kostaras, Derek Tilley, Michael Chu, Carolyn J. Owen & Douglas A. Stewart
Pages: 1756-1762
Published online: 03 Nov 2014
AbstractforComparative effectiveness analysis of different salvage therapy intensities used for diffuse large B-cell lymphoma in Northern or Southern Alberta: an instrumental variable analysis | Full Text | References | PDF (331.2 KB) | Supplemental
  • 298 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Efficacy, safety, pharmacokinetics and pharmacodynamics of SAR245409 (voxtalisib, XL765), an orally administered phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor: a phase 1 expansion cohort in patients with relapsed or refractory lymphoma
Kyriakos P. Papadopoulos, Coumaran Egile, Rodrigo Ruiz-Soto, Jason Jiang, Weiliang Shi, Frauke Bentzien, Drew Rasco, Pau Abrisqueta, Julie M. Vose & Josep Tabernero
Pages: 1763-1770
Published online: 19 Nov 2014
AbstractforEfficacy, safety, pharmacokinetics and pharmacodynamics of SAR245409 (voxtalisib, XL765), an orally administered phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor: a phase 1 expansion cohort in patients with relapsed or refractory lymphoma | Full Text | References | PDF (7.4 MB) | Supplemental
  • 473 Views
  • 22 CrossRef citations
  • 0Altmetric
Article
Incidence of chronic myeloid leukemia and patient survival: results of five French population-based cancer registries 1980–2009
Amélie Penot, Pierre-Marie Preux, Sandra Le Guyader, Albert Collignon, Aurélie Herry, Vinciane Dufour, Alain Monnereau, Anne-Sophie Woronoff, Xavier Troussard, Elisabeth Pons, Dominique Bordessoule & Marc Maynadié
Pages: 1771-1777
Published online: 29 Jan 2015
AbstractforIncidence of chronic myeloid leukemia and patient survival: results of five French population-based cancer registries 1980–2009 | Full Text | References | PDF (676.3 KB) | Supplemental
  • 313 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Prognostic implications of CD30 expression in extranodal natural killer/T-cell lymphoma according to treatment modalities
Wook Youn Kim, Soo Jeong Nam, Sehui Kim, Tae Min Kim, Dae Seog Heo, Chul-Woo Kim & Yoon Kyung Jeon
Pages: 1778-1786
Published online: 14 Nov 2014
AbstractforPrognostic implications of CD30 expression in extranodal natural killer/T-cell lymphoma according to treatment modalities | Full Text | References | PDF (720 KB) | Supplemental
  • 588 Views
  • 42 CrossRef citations
  • 0Altmetric
Article
Molecular responses at 3 and 6 months after switching to a second-generation tyrosine kinase inhibitor are complementary and predictive of long-term outcomes in patients with chronic myeloid leukemia who fail imatinib
Carla Boquimpani, Rony Schaffel, Irene Biasoli, Israel Bendit & Nelson Spector
Pages: 1787-1792
Published online: 20 Nov 2014
AbstractforMolecular responses at 3 and 6 months after switching to a second-generation tyrosine kinase inhibitor are complementary and predictive of long-term outcomes in patients with chronic myeloid leukemia who fail imatinib | Full Text | References | PDF (420.6 KB) | Supplemental
  • 378 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Polymorphisms in TNF and IFNG are associated with clinical characteristics of aplastic anemia in Argentinean population
Yesica Bestach, Yamila Sieza, Myriam Attie, Cecilia Riccheri, Verónica Verri, Moira Bolesina, Raquel Bengió, Irene Larripa & Carolina Belli
Pages: 1793-1798
Published online: 21 Jan 2015
AbstractforPolymorphisms in TNF and IFNG are associated with clinical characteristics of aplastic anemia in Argentinean population | Full Text | References | PDF (148.1 KB) | Supplemental
  • 150 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant
Parastoo B. Dahi, Miguel A. Perales, Sean M. Devlin, Amanda Olson, Marissa Lubin, Anne Marie Gonzales, Andromachi Scaradavou, Nancy A. Kernan, Richard J. O’Reilly, Sergio Giralt, Ann Jakubowski, Guenther Koehne, Esperanza B. Papadopoulos, Doris M. Ponce, Craig Sauter, Genovefa Papanicolaou & Juliet N. Barker
Pages: 1799-1805
Published online: 21 Oct 2014
AbstractforIncidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant | Full Text | References | PDF (254.5 KB) | Supplemental
  • 316 Views
  • 27 CrossRef citations
  • 0Altmetric
Article
The incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type 1 carriers in Japan
Masahiro Satake, Yasuaki Yamada, Sunao Atogami & Kazunari Yamaguchi
Pages: 1806-1812
Published online: 21 Jan 2015
AbstractforThe incidence of adult T-cell leukemia/lymphoma among human T-lymphotropic virus type 1 carriers in Japan | Full Text | References | PDF (595.2 KB) | Supplemental
  • 294 Views
  • 32 CrossRef citations
  • 0Altmetric

Original Article: Research

Article
Kinesin spindle protein inhibitor SB743921 induces mitotic arrest and apoptosis and overcomes imatinib resistance of chronic myeloid leukemia cells
Yue Yin, Huiyan Sun, Jun Xu, Fengjun Xiao, Hua Wang, Yuefeng Yang, Hanyun Ren, Chu-Tse Wu, Chunji Gao & Lisheng Wang
Pages: 1813-1820
Published online: 22 Sep 2014
AbstractforKinesin spindle protein inhibitor SB743921 induces mitotic arrest and apoptosis and overcomes imatinib resistance of chronic myeloid leukemia cells | Full Text | References | PDF (3 MB) | Supplemental
  • 502 Views
  • 14 CrossRef citations
  • 0Altmetric
Article
Glycolytic inhibitor 2-deoxy-d-glucose suppresses cell proliferation and enhances methylprednisolone sensitivity in non-Hodgkin lymphoma cells through down-regulation of HIF-1α and c-MYC
Yu-Yang Pang, Ting Wang, Fang-Yuan Chen, Ying-Li Wu, Xia Shao, Fei Xiao, Hong-Hui Huang, Hua Zhong & Ji-Hua Zhong
Pages: 1821-1830
Published online: 21 Oct 2014
AbstractforGlycolytic inhibitor 2-deoxy-d-glucose suppresses cell proliferation and enhances methylprednisolone sensitivity in non-Hodgkin lymphoma cells through down-regulation of HIF-1α and c-MYC | Full Text | References | PDF (2.9 MB) | Supplemental
  • 386 Views
  • 23 CrossRef citations
  • 0Altmetric
Article
A study for proposal of use of regulatory T cells as a prognostic marker and establishing an optimal threshold level for their expression in chronic lymphocytic leukemia
Alakananda Dasgupta, Manoranjan Mahapatra & Renu Saxena
Pages: 1831-1838
Published online: 28 Oct 2014
AbstractforA study for proposal of use of regulatory T cells as a prognostic marker and establishing an optimal threshold level for their expression in chronic lymphocytic leukemia | Full Text | References | PDF (449.4 KB) | Supplemental
  • 185 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Health utilities in relation to treatment response and adverse events in relapsed/refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma
Paul Swinburn, Sarah Shingler, Sarah Acaster, Andrew Lloyd & Vijayveer Bonthapally
Pages: 1839-1845
Published online: 03 Nov 2014
AbstractforHealth utilities in relation to treatment response and adverse events in relapsed/refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma | Full Text | References | PDF (158 KB) | Supplemental
  • 649 Views
  • 20 CrossRef citations
  • 0Altmetric
Article
Activation of p53-dependent/-independent pathways of apoptotic cell death by chelerythrine in a murine T cell lymphoma
Sanjay Kumar, Munendra Singh Tomar & Arbind Acharya
Pages: 1846-1855
Published online: 08 Jan 2015
AbstractforActivation of p53-dependent/-independent pathways of apoptotic cell death by chelerythrine in a murine T cell lymphoma | Full Text | References | PDF (2.7 MB) | Supplemental
  • 172 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
Polymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population
Kais Douzi, Slah Ouerhani, Samia Menif, Ines Safra & Salem Abbes
Pages: 1856-1862
Published online: 14 Nov 2014
AbstractforPolymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population | Full Text | References | PDF (143.9 KB) | Supplemental
  • 165 Views
  • 14 CrossRef citations
  • 0Altmetric
Article
Ceramide participates in lysosome-mediated cell death induced by type II anti-CD20 monoclonal antibodies
Yuzhi Liu, Ling Shu & Jingjing Wu
Pages: 1863-1868
Published online: 14 Jan 2015
AbstractforCeramide participates in lysosome-mediated cell death induced by type II anti-CD20 monoclonal antibodies | Full Text | References | PDF (3.6 MB) | Supplemental
  • 201 Views
  • 3 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter
Central nervous system relapse in patients with diffuse large B-cell lymphoma: analysis of incidence and prognostic factors
Masahiro Uni, Yuki Kagoya, Yasuhito Nannya, Fumihiko Nakamura & Mineo Kurokawa
Pages: 1869-1871
Published online: 05 Nov 2014
First Page PreviewforCentral nervous system relapse in patients with diffuse large B-cell lymphoma: analysis of incidence and prognostic factors | Full Text | References | PDF (185.4 KB) | Supplemental
  • 287 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Erythema multiforme-like reaction with mucosal involvement following administration of idelalisib for relapse of chronic lymphocytic leukemia
Tarek Yamany, Michelle Levender, David N. Silvers & Marc E. Grossman
Pages: 1872-1873
Published online: 19 Nov 2014
CitationforErythema multiforme-like reaction with mucosal involvement following administration of idelalisib for relapse of chronic lymphocytic leukemia | Full Text | References | PDF (375.3 KB) | Supplemental
  • 199 Views
  • 5 CrossRef citations
  • 0Altmetric
Letter
Clinical impact of CD25 expression on outcomes of allogeneic hematopoietic stem cell transplant for cytogenetically intermediate-risk acute myeloid leukemia
Shuntaro Ikegawa, Noriko Doki, Keita Yamamoto, Naoki Shingai, Yukie Takahashi, Jun Aoki, Kosuke Yoshioka, Kensuke Narukawa, Shinya Ishida, Aiko Igarashi, Gaku Oshikawa, Takeshi Kobayashi, Kazuhiko Kakihana, Hisashi Sakamaki, Kyoko Haraguchi, Yoshiki Okuyama & Kazuteru Ohashi
Pages: 1874-1877
Published online: 14 Nov 2014
First Page PreviewforClinical impact of CD25 expression on outcomes of allogeneic hematopoietic stem cell transplant for cytogenetically intermediate-risk acute myeloid leukemia | Full Text | References | PDF (207.8 KB) | Supplemental
  • 152 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia
Paolo Strati, Wei-Gang Tong, Candida Vitale, William G. Wierda, Susan O’Brien, Jennifer R. Brown, Wen-Kai Weng, Thomas Kipps, Michael J. Keating & Alessandra Ferrajoli
Pages: 1878-1880
Published online: 20 Nov 2014
First Page PreviewforA phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia | Full Text | References | PDF (164 KB) | Supplemental
  • 226 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
ASXL1 mutations define a subgroup of patients with acute myeloid leukemia with distinct gene expression profile and poor prognosis: a meta-analysis of 3311 adult patients with acute myeloid leukemia
Velizar Shivarov, Ralitza Gueorguieva, Milena Ivanova & Ramon V. Tiu
Pages: 1881-1883
Published online: 08 Jan 2015
First Page PreviewforASXL1 mutations define a subgroup of patients with acute myeloid leukemia with distinct gene expression profile and poor prognosis: a meta-analysis of 3311 adult patients with acute myeloid leukemia | Full Text | References | PDF (1.8 MB) | Supplemental
  • 338 Views
  • 8 CrossRef citations
  • 0Altmetric
Letter
Multiplex ligation-dependent probe amplification validates LOH6q analyses and enhances insight into chromosome 6q aberrations in pediatric T-cell lymphoblastic leukemia and lymphoma
Marius Rohde, Bettina R. Bonn, Martin Zimmermann, Monika Szczepanowski, Christine Damm-Welk, Martin Stanulla & Birgit Burkhardt
Pages: 1884-1887
Published online: 19 Nov 2014
First Page PreviewforMultiplex ligation-dependent probe amplification validates LOH6q analyses and enhances insight into chromosome 6q aberrations in pediatric T-cell lymphoblastic leukemia and lymphoma | Full Text | References | PDF (1.2 MB) | Supplemental
  • 123 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Screening for SF3B1 mutations is a useful tool to differentiate between acquired clonal and non-clonal sideroblastic anemia
Valeria Visconte, Ali Tabarroki, Christopher J. Gerace, Karam Al-Issa, Eric D. Hsi, Heesun J. Rogers, Mikkael A. Sekeres, Bernard J. Silver, Alan E. Lichtin, Sudipto Mukherjee & Ramon V. Tiu
Pages: 1888-1890
Published online: 14 Nov 2014
First Page PreviewforScreening for SF3B1 mutations is a useful tool to differentiate between acquired clonal and non-clonal sideroblastic anemia | Full Text | References | PDF (102.4 KB) | Supplemental
  • 228 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Lymphocytic variant hypereosinophilic syndrome progressing to angioimmunoblastic T-cell lymphoma
Florence Roufosse, Laurence de Leval, Han van Krieken & Marcel van Deuren
Pages: 1891-1894
Published online: 19 Nov 2014
First Page PreviewforLymphocytic variant hypereosinophilic syndrome progressing to angioimmunoblastic T-cell lymphoma | Full Text | References | PDF (8.1 MB) | Supplemental
  • 521 Views
  • 11 CrossRef citations
  • 0Altmetric
Letter
Lenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome: a retrospective case series of eight patients
Elsa Lestang, Aurelie Caristan, Antoine Néel, Julie Graveleau, Elisabeth Duhamel, Agathe Masseau, Jerome Connault, Hervè Maisonneuve, Steven Le Gouill, Nicolas Blin, Cyrille Touzeau, Philippe Moreau & Mohamed Hamidou
Pages: 1895-1896
Published online: 21 Jan 2015
CitationforLenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome: a retrospective case series of eight patients | Full Text | References | PDF (127.5 KB) | Supplemental
  • 318 Views
  • 7 CrossRef citations
  • 0Altmetric
Letter
Up-regulation of CXCL8/interleukin-8 production in response to CXCL12 in chronic lymphocytic leukemia
Omar Perbellini, Federica Cioffi, Giorgio Malpeli, Elisabetta Zanolin, Ornella Lovato, Aldo Scarpa, Giovanni Pizzolo & Maria T. Scupoli
Pages: 1897-1900
Published online: 19 Nov 2014
First Page PreviewforUp-regulation of CXCL8/interleukin-8 production in response to CXCL12 in chronic lymphocytic leukemia | Full Text | References | PDF (280.3 KB) | Supplemental
  • 235 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Panobinostat in combination with bortezomib and dexamethasone as induction therapy in patients with multiple myeloma, candidates for autologous transplant
Silvia Mangiacavalli, Lara Pochintesta, Erika Ravelli, Luca Baldini, Virginia Valeria Ferretti, Maria Luisa La Targia, Lucia Farina, Federica Cocito, Roberto Cairoli, Vittorio Montefusco & Alessandro Corso
Pages: 1901-1902
Published online: 14 Jan 2015
CitationforPanobinostat in combination with bortezomib and dexamethasone as induction therapy in patients with multiple myeloma, candidates for autologous transplant | Full Text | References | PDF (92.3 KB) | Supplemental
  • 768 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
The association between opioid administration and response to therapy in patients with acute lymphoblastic leukemia
Pascal Owusu-Agyemang, Gautam Borthakur, Elizabeth Rebello, Radha Arunkumar, Sa A. Wang, Michael Rytting, Jeffrey L. Jorgensen, Mike Hernandez, Joseph R. Ruiz & Juan P. Cata
Pages: 1903-1905
Published online: 14 Jan 2015
First Page PreviewforThe association between opioid administration and response to therapy in patients with acute lymphoblastic leukemia | Full Text | References | PDF (99.7 KB) | Supplemental
  • 155 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Faggot-like cells observed in acute myeloid leukemia with myelodysplasia-related changes mimicking acute promyelocytic leukemia
Yong Won Choi, Joon Seong Park, Yu Soek Jung & Sung Ran Cho
Pages: 1906-1907
Published online: 14 Jan 2015
CitationforFaggot-like cells observed in acute myeloid leukemia with myelodysplasia-related changes mimicking acute promyelocytic leukemia | Full Text | References | PDF (121.1 KB) | Supplemental
  • 142 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Clonal Epstein–Barr virus-positive mucocutaneous ulcer mimicking a mature B-cell lymphoma in a patient with mycophenolate-induced immune suppression
Melanny Kanemitsu, David John, Anthony Lim, Elaine S. Jaffe & Joseph Aoki
Pages: 1908-1910
Published online: 21 Jan 2015
First Page PreviewforClonal Epstein–Barr virus-positive mucocutaneous ulcer mimicking a mature B-cell lymphoma in a patient with mycophenolate-induced immune suppression | Full Text | References | PDF (627.8 KB) | Supplemental
  • 229 Views
  • 19 CrossRef citations
  • 0Altmetric
Letter
Efficacy and side-effects of decitabine in treatment of atypical chronic myeloid leukemia
Xiuzhen Tong, Juan Li, Zhenhai Zhou, Dong Zheng, Junru Liu & Chang Su
Pages: 1911-1913
Published online: 14 Feb 2015
First Page PreviewforEfficacy and side-effects of decitabine in treatment of atypical chronic myeloid leukemia | Full Text | References | PDF (146.4 KB) | Supplemental
  • 464 Views
  • 20 CrossRef citations
  • 0Altmetric
Letter
Is GDF15 beneficial to erythropoiesis in low grade myelodysplastic syndrome?
Darren O'Toole, Paul Kennedy, John Quinn & Philip Thomas Murphy
Pages: 1914-1915
Published online: 14 Jan 2015
CitationforIs GDF15 beneficial to erythropoiesis in low grade myelodysplastic syndrome? | Full Text | References | PDF (115.3 KB) | Supplemental
  • 114 Views
  • 1 CrossRef citations
  • 0Altmetric

Correspondence

Oral low-dose fludarabine and cyclophosphamide with rituximab as initial treatment for elderly patients with chronic lymphoproliferative disorders
Alessandro Gozzetti, Alberto Fabbri, Emanuele Cencini & Monica Bocchia
Pages: 1916-1917
Published online: 19 Nov 2014
CitationforOral low-dose fludarabine and cyclophosphamide with rituximab as initial treatment for elderly patients with chronic lymphoproliferative disorders | Full Text | References | PDF (85.4 KB) | Supplemental
  • 93 Views
  • 1 CrossRef citations
  • 0Altmetric
Response to the letter from Gozzetti et al. entitled: “Oral low-dose fludarabine and cyclophosphamide with rituximab as initial treatment for elderly patients with chronic lymphoproliferative disorders”
Simon Rule
Page: 1918
Published online: 02 Dec 2014
CitationforResponse to the letter from Gozzetti et al. entitled: “Oral low-dose fludarabine and cyclophosphamide with rituximab as initial treatment for elderly patients with chronic lymphoproliferative disorders” | Full Text | References | PDF (77.3 KB) | Supplemental
  • 60 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

High red cell mass and high plasma volume are independently associated with thrombotic risk in polycythemia vera
Ivan Krecak et al.
Letter to the Editor | Published online: 20 Jun 2024
Experience of using venetoclax in relapsed T- cell lymphoma
Jasmine Zain et al.
Letter to the Editor | Published online: 17 Jun 2024
Therapy-related myeloid neoplasms with single-hit TP53 mutations share the clinical, molecular, and survival characteristics of their multi-hit counterparts
Taylor Zak et al.
Article | Published online: 17 Jun 2024
Polycythemia vera: past, present and future
Ami B. Patel et al.
Review Article | Published online: 13 Jun 2024
View all latest articles